112 results
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
27 Mar 24
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
8:35pm
adverse clinical outcomes. The burden of managing uncontrolled anemia in CKD patients can be substantial, both in terms of healthcare costs and the impact … on patients, healthcare providers and caregivers. Today, most CKD patients are treated for anemia with injectable erythropoiesis-stimulating agents
8-K
g2vsfic2bl
8 Jan 24
Results of Operations and Financial Condition
8:02am
8-K
EX-99.1
8pe5o83nd8uf3pnlqi
25 Aug 23
Akebia Therapeutics Reports Second Quarter 2023 Financial Results
8:14am
8-K
pw9 gtrg276ruegvw
7 Jun 23
Regulation FD Disclosure
7:31am
8-K
EX-99.1
rshhedj ys
7 Jun 23
Regulation FD Disclosure
7:31am
8-K
EX-99.1
ua3zay ixnyuttw
30 May 23
Regulation FD Disclosure
7:34am
8-K
EX-99.1
zbjmrees
25 May 23
Entry into a Material Definitive Agreement
8:05am
8-K
5l2z10h
15 Dec 22
Departure of Directors or Certain Officers
4:09pm
8-K
eeyeg2ynrwyxjz5n
8 Nov 22
Cost Associated with Exit or Disposal Activities
4:06pm